Tag Archives: Gilead

Gilead – HIV Treatment – Indian companies

[businesswire] Gilead Sciences, Inc. announced today an expansion of its global access program in an effort to provide accelerated access to Gilead medicines for the treatment of HIV/AIDS. The changes announced today include new licensing terms with four India-based drug … Continue reading

Posted in Daily interesting IP news | Tagged , , , , , | Leave a comment

Natco Gilead Tamiflu ANDA

Today Natco confirmed the first to file status in press release and will have 180 days exclusivity if Natco ANDA approved by FDA. Natco ties up with Alvogen for marketing generic version in USA. As of now, Gilead has not sued … Continue reading

Posted in Patent case | Tagged , , , | 1 Comment

CI & Patent News: 23/11/2010a

1) Vertex Completes New Drug Application for Telaprevir for Hepatitis C (Link) 2) Gilead Sciences Submits New Drug Application to U.S. FDA for Once-Daily Single-Tablet Regimen of Truvada® (emtricitabine and tenofovir disoproxil fumarate)and TMC278 (rilpivirine hydrochloride) for HIV (Link) 3) Wockhardt Ltd. has … Continue reading

Posted in Daily interesting IP news | Tagged , , , | Leave a comment